10/18/2025
Read below about ground breaking research regarding Neuro inflammation and modalities that can help!  
Identifying Neuroinflammation: The Diagnostic Potential of Spindling Excessive Beta in the EEG
https://hnbraincenter.com/research/identifying-neuroinflammation-the-diagnostic-potential-of-spindling-excessive-beta-in-the-eeg/
Houston Neuroscience Brain Center has published groundbreaking research that could change the way clinicians detect and monitor brain inflammation. For decades, identifying neuroinflammation—a chronic immune response in the brain linked to psychiatric illness, traumatic brain injury (TBI), and neurodegeneration—has relied on costly, invasive procedures. But this new study highlights a non-invasive, cost-effective alternative: electroencephalography (EEG).
The research focuses on a unique EEG pattern known as spindling excessive beta, which shows strong potential as a biomarker for neuroinflammatory states. You can read the full study here.
What Is Neuroinflammation?
Neuroinflammation is the brain’s built-in defense against infection, toxins, trauma, or stress. In its acute phase, it helps protect the nervous system. But when it becomes chronic, it can:
Damage neurons through excessive cytokine release
Contribute to cognitive decline and memory loss
Trigger psychiatric disturbances such as depression and anxiety
Increase risk for neurodegenerative diseases like Alzheimer’s
Common symptoms of neuroinflammation include fatigue, brain fog, poor memory, sleep disturbance, and mood changes—symptoms often mistaken for psychiatric illness alone.
Why Current Diagnostic Tools Fall Short
Traditional methods for detecting neuroinflammation are either invasive or limited in scope:
Lumbar puncture (spinal tap): painful, invasive, and prone to false negatives
MRI scans: can show lesions but miss subtle inflammatory activity
PET scans: sensitive but costly and reliant on specialized tracers
Blood biomarkers: validated for certain conditions (like TBI) but not broad neuroinflammation
Brain biopsy: definitive but far too invasive for routine use
Clearly, clinicians need a non-invasive, reliable, and affordable tool for identifying neuroinflammation in real time.
EEG and the Discovery of Spindling Excessive Beta
EEG has long been used to measure brain activity in epilepsy and encephalopathy. Now, it is emerging as a powerful diagnostic tool for neuroinflammation.
The Houston Neuroscience Brain Center study examined EEGs from 1,233 treatment-resistant psychiatric patients, including 79 adults with TBI. Researchers identified a distinct pattern called spindling excessive beta—a sinusoidal, spindle-shaped beta activity between 13–35 Hz.
Key Findings:
Prevalence: Spindling excessive beta was present in 25% of the entire cohort, but prevalence skyrocketed to 78% in adults with TBI.
Location: Non-TBI patients showed frontal and central spindling, while TBI patients exhibited temporal lobe shifts—a region particularly vulnerable in head injuries.
S*x and Age Differences: Adults and females showed higher prevalence, reflecting known patterns in psychiatric illness and anxiety disorders.
Diagnostic Accuracy: Logistic regression analysis classified TBI cases with 85% accuracy, making it a highly promising clinical marker.
Why This Matters for Patients and Clinicians
Identifying spindling excessive beta as a reliable EEG biomarker opens doors for:
Earlier Detection – Catching chronic inflammation before it progresses to cognitive decline or psychiatric instability.
Personalized Treatment – Moving beyond symptom-based care to target underlying brain physiology.
Treatment Monitoring – EEG can track improvements over time, showing whether interventions are reducing inflammation.
Interventions That Show Promise
The study also noted that treatments targeting inflammation and cerebral blood flow correlated with reductions in spindling excessive beta. These included:
Guanfacine combined with N-acetylcysteine (NAC)
Photobiomodulation (light therapy)
Hyperbaric oxygen therapy
By incorporating EEG biomarkers into routine care, psychiatrists and neurologists may soon offer precision psychiatry—where treatments are guided by brain physiology, not just patient-reported symptoms.
